Periprosthetic Knee InfectionNCT03435679
One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty
A study testing one-stage and two-stage in people with Periprosthetic Knee Infection, run by Odense University Hospital at 9 sites in Denmark.
Trial summary
This study investigates functional outcome and safety after one-stage versus two-stage revision of the infected knee arthroplasty. Half of participants are treated with a one-stage surgical procedure, while the other half is treated with a two-stage procedure. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Periprosthetic Knee Infection
- What is being tested?
- one-stage and two-stage
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 97 participants
- Where
- 9 sitesDenmark
- Study dates
- 1 Mar 2018to 18 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Clinical signs of periprosthetic knee infection
- > 6 weeks from previous knee arthoplasty procedure (primary or total revision procedure)
- Speak and understand Danish and have given informed consent
Who cannot join
- Soft tissue problems requiring plastic surgery
- major bone loss requiring mega/tumor-prosthesis
- acute surgery due to sepsis
- malignant disease with less than 2 years life expectancy
- re-infection with previous two-stage procedure
- bilateral knee infection
Trial locations and contacts
9 sites in 1 country.
9 sites in 1 country
Denmark9 sites
Aalborg University Hospital
Aalborg
Bispebjerg Hospital
Copenhagen
Gentofte Hospital
Copenhagen
Hvidovre Hospital
Copenhagen
Rigshospitalet
Copenhagen
Horsens Hospital
Horsens
Næstved Hospital
Næstved
Odense Universitets Hospital
Odense
Vejle Hospital
Vejle
About this study
Official title: One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty. a Randomized Controlled Multicenter Trial.
This study investigates functional outcome and safety after one-stage versus two-stage revision of the infected knee arthroplasty.
Half of participants are treated with a one-stage surgical procedure, while the other half is treated with a two-stage procedure.
The investigators hypothesize that the functional outcome and quality of life of the participants is superior after one-stage surgery compared to two-stage surgery.
Read the detailed description
A two-stage approach is the standard surgical procedure in the treatment of the chronically infected knee arthroplasty, but promising results have been reported after a one-stage approach from single-centre studies.
The potential benefits for the patients treated with a one-stage approach are many as they only have to go through surgery and rehabilitation once with shorter total length of hospital stay. However, no randomized controlled trials comparing outcome after the procedures have been performed so far.
- Conditions
- Periprosthetic Knee Infection
- Being tested
- one-stage, two-stage
- Keywords
- infection, knee arthroplasty, surgical treatment, one-stage, two-stage, outcome
- Medical subject headings
- Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
one-stageProcedure or surgery
one-stage surgery
two-stageProcedure or surgery
two-stage surgery
| Study group | Role | What they receive |
|---|---|---|
| one-stage | Experimental | one-stage surgical treatment of the infected knee arthroplasty Receives: Procedure: one-stage |
| two-stage | Active comparator | two-stage surgical treatment of the infected knee arthroplasty with a interim period of 8-10 weeks between stages Receives: Procedure: two-stage |
What is being measured
The primary outcome is the main question the study is designed to answer.
Oxford Knee Score (AUC)
Area Under Curve for Oxford Knee Score
Measured: preoperatively 6 weeks, 3, 6, 9, 12 months postoperatively.
Secondary outcomes (6)
Oxford Knee Score (AUC)
Area Under Curve for Oxford Knee Score
Measured: preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperatively.
EQ-5D-5L
Quality of life questionnaire
Measured: preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperatively.
Re-revision rate
re-revisions due to infection and other causes
Measured: 2 year postoperatively
mortality
postoperative mortality
Measured: 90 days postoperatively and 1 and 2 year postoperatively
readmission rate
postoperative readmission rate
Measured: 90 days postoperatively
Range of Motion
Range of motion of the infected/operated knee
Measured: 2 years postoperatively
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Feb 2018
- Study start1 Mar 2018
- Primary completion18 Nov 2025 (estimated)
- Study completion18 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for Periprosthetic Knee InfectionStudies of the same condition, open and under way.
- More trials run by Odense University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 97 participants (actual)
Sponsor and investigators
- Lead sponsor
- Odense University Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Odense Patient Data Explorative Network, Region of Southern Denmark
- Responsible party
- Principal investigator, Martin Lindberg-Larsen, Odense University Hospital
- Investigators
- Martin Lindberg-Larsen, Principal investigator, Martin Lindberg-Larsen
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03435679
- Sponsor's protocol ID
- MLL_02_2018
- Status last verified
- Dec 2024
- First submitted
- 31 Jan 2018
- Last updated
- 11 Dec 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: According to local interpretation of GDPR. Blinded data can be provided upon request.
Publications
Lindberg-Larsen M, Jorgensen CC, Bagger J, Schroder HM, Kehlet H. Revision of infected knee arthroplasties in Denmark. Acta Orthop. 2016 Aug;87(4):333-8. doi: 10.3109/17453674.2016.1148453. Epub 2016 Feb 22.
PubMed 26900908Lindberg-Larsen M, Pitter FT, Voldstedlund M, Schroder HM, Bagger J. Microbiological diagnosis in revision of infected knee arthroplasties in Denmark. Infect Dis (Lond). 2017 Nov-Dec;49(11-12):824-830. doi: 10.1080/23744235.2017.1350878. Epub 2017 Jul 8.
PubMed 28691647Masters JP, Smith NA, Foguet P, Reed M, Parsons H, Sprowson AP. A systematic review of the evidence for single stage and two stage revision of infected knee replacement. BMC Musculoskelet Disord. 2013 Jul 29;14:222. doi: 10.1186/1471-2474-14-222.
PubMed 23895421Haddad FS, Sukeik M, Alazzawi S. Is single-stage revision according to a strict protocol effective in treatment of chronic knee arthroplasty infections? Clin Orthop Relat Res. 2015 Jan;473(1):8-14. doi: 10.1007/s11999-014-3721-8.
PubMed 24923669Singer J, Merz A, Frommelt L, Fink B. High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE. Clin Orthop Relat Res. 2012 May;470(5):1461-71. doi: 10.1007/s11999-011-2174-6. Epub 2011 Nov 12.
PubMed 22081299Baker P, Petheram TG, Kurtz S, Konttinen YT, Gregg P, Deehan D. Patient reported outcome measures after revision of the infected TKR: comparison of single versus two-stage revision. Knee Surg Sports Traumatol Arthrosc. 2013 Dec;21(12):2713-20. doi: 10.1007/s00167-012-2090-7. Epub 2012 Jun 13.
PubMed 22692517Massin P, Delory T, Lhotellier L, Pasquier G, Roche O, Cazenave A, Estellat C, Jenny JY. Infection recurrence factors in one- and two-stage total knee prosthesis exchanges. Knee Surg Sports Traumatol Arthrosc. 2016 Oct;24(10):3131-3139. doi: 10.1007/s00167-015-3884-1. Epub 2015 Nov 26.
PubMed 26611899Lindberg-Larsen M, Odgaard A, Fredborg C, Schroder HM; One-stage vs Two-stage Collaboration Group. One-stage versus two-stage revision of the infected knee arthroplasty - a randomized multicenter clinical trial study protocol. BMC Musculoskelet Disord. 2021 Feb 12;22(1):175. doi: 10.1186/s12891-021-04044-8.
PubMed 33579256
Study at a glance
From the registry record, last updated by the sponsor on 11 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty. a Randomized Controlled Multicenter Trial.
- ClinicalTrials.gov ID
- NCT03435679
- Acronym / sponsor ID
- MLL_02_2018
- Conditions
- Periprosthetic Knee Infection
- Keywords
- infection, knee arthroplasty, surgical treatment, one-stage, two-stage, outcome
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 97 participants (actual)
- Lead sponsor
- Odense University HospitalUniversity, hospital or other
- Collaborators
- Odense Patient Data Explorative Network, Region of Southern Denmark
- Study start
- 1 Mar 2018 (actual)
- Primary completion
- 18 Nov 2025 (estimated)
- Study completion
- 18 Nov 2026 (estimated)
- First posted
- 19 Feb 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigates functional outcome and safety after one-stage versus two-stage revision of the infected knee arthroplasty.
Half of participants are treated with a one-stage surgical procedure, while the other half is treated with a two-stage procedure.
The investigators hypothesize that the functional outcome and quality of life of the participants is superior after one-stage surgery compared to two-stage surgery.
Detailed description
A two-stage approach is the standard surgical procedure in the treatment of the chronically infected knee arthroplasty, but promising results have been reported after a one-stage approach from single-centre studies.
The potential benefits for the patients treated with a one-stage approach are many as they only have to go through surgery and rehabilitation once with shorter total length of hospital stay. However, no randomized controlled trials comparing outcome after the procedures have been performed so far.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| one-stage | Experimental | Procedure: one-stageone-stage surgical treatment of the infected knee arthroplasty |
| two-stage | Active comparator | Procedure: two-stagetwo-stage surgical treatment of the infected knee arthroplasty with a interim period of 8-10 weeks between stages |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (3 listed)
- Clinical signs of periprosthetic knee infection
- > 6 weeks from previous knee arthoplasty procedure (primary or total revision procedure)
- Speak and understand Danish and have given informed consent
Key exclusion criteria (6 listed)
- Soft tissue problems requiring plastic surgery
- major bone loss requiring mega/tumor-prosthesis
- acute surgery due to sepsis
- malignant disease with less than 2 years life expectancy
- re-infection with previous two-stage procedure
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| one-stageone-stage surgery | Procedure or surgery | one-stage |
| two-stagetwo-stage surgery | Procedure or surgery | two-stage |
Primary outcome
Oxford Knee Score (AUC)
Time frame: preoperatively 6 weeks, 3, 6, 9, 12 months postoperatively.
Area Under Curve for Oxford Knee Score
6 secondary outcomes
Oxford Knee Score (AUC)
Time frame: preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperatively.
EQ-5D-5L
Time frame: preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperatively.
Re-revision rate
Time frame: 2 year postoperatively
mortality
Time frame: 90 days postoperatively and 1 and 2 year postoperatively
readmission rate
Time frame: 90 days postoperatively
Range of Motion
Time frame: 2 years postoperatively
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Dec 2024.
- Background: PubMed 26900908Lindberg-Larsen M, Jorgensen CC, Bagger J, Schroder HM, Kehlet H. Revision of infected knee arthroplasties in Denmark. Acta Orthop. 2016 Aug;87(4):333-8. doi: 10.3109/17453674.2016.1148453. Epub 2016 Feb 22.
- Background: PubMed 28691647Lindberg-Larsen M, Pitter FT, Voldstedlund M, Schroder HM, Bagger J. Microbiological diagnosis in revision of infected knee arthroplasties in Denmark. Infect Dis (Lond). 2017 Nov-Dec;49(11-12):824-830. doi: 10.1080/23744235.2017.1350878. Epub 2017 Jul 8.
- Background: PubMed 23895421Masters JP, Smith NA, Foguet P, Reed M, Parsons H, Sprowson AP. A systematic review of the evidence for single stage and two stage revision of infected knee replacement. BMC Musculoskelet Disord. 2013 Jul 29;14:222. doi: 10.1186/1471-2474-14-222.
- Background: PubMed 24923669Haddad FS, Sukeik M, Alazzawi S. Is single-stage revision according to a strict protocol effective in treatment of chronic knee arthroplasty infections? Clin Orthop Relat Res. 2015 Jan;473(1):8-14. doi: 10.1007/s11999-014-3721-8.
- Background: PubMed 22081299Singer J, Merz A, Frommelt L, Fink B. High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE. Clin Orthop Relat Res. 2012 May;470(5):1461-71. doi: 10.1007/s11999-011-2174-6. Epub 2011 Nov 12.
- Background: PubMed 22692517Baker P, Petheram TG, Kurtz S, Konttinen YT, Gregg P, Deehan D. Patient reported outcome measures after revision of the infected TKR: comparison of single versus two-stage revision. Knee Surg Sports Traumatol Arthrosc. 2013 Dec;21(12):2713-20. doi: 10.1007/s00167-012-2090-7. Epub 2012 Jun 13.
- Background: PubMed 26611899Massin P, Delory T, Lhotellier L, Pasquier G, Roche O, Cazenave A, Estellat C, Jenny JY. Infection recurrence factors in one- and two-stage total knee prosthesis exchanges. Knee Surg Sports Traumatol Arthrosc. 2016 Oct;24(10):3131-3139. doi: 10.1007/s00167-015-3884-1. Epub 2015 Nov 26.
- Derived from this study: PubMed 33579256Lindberg-Larsen M, Odgaard A, Fredborg C, Schroder HM; One-stage vs Two-stage Collaboration Group. One-stage versus two-stage revision of the infected knee arthroplasty - a randomized multicenter clinical trial study protocol. BMC Musculoskelet Disord. 2021 Feb 12;22(1):175. doi: 10.1186/s12891-021-04044-8.
- Individual participant dataSharing planned: No. According to local interpretation of GDPR. Blinded data can be provided upon request.
Related trials for Periprosthetic Knee Infection
Recruiting
Sola2 AMF Knee System Added to Surgery and Antibiotics in Adults With Knee Implant Infection
Prosthetic Joint Infection of Knee
RecruitingPhase 2/3
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
Prosthetic-joint Infection
RecruitingPhase 2
Periprosthetic Joint Infection Bubble Study
Periprosthetic Joint Infection (PJI)
RecruitingObservational study
Analysis of the Etiopathogenesis of Postoperative Complications in Orthopedic Patients Using Knee and Hip Arthroplasty as an Example
Periprosthetic Joint Infection (PJI), Periprosthetic Knee Infection
Recruiting
Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection
Prosthetic-joint Infection, Knee Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Martin Lindberg-Larsen principal investigator
Martin Lindberg-Larsen
9 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing one-stage and two-stage in people with Periprosthetic Knee Infection, run by Odense University Hospital at 9 sites in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 11 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 9 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Oxford Knee Score (AUC) (time frame: preoperatively 6 weeks, 3, 6, 9, 12 months postoperatively.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03435679, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2024.